Success Metrics

Clinical Success Rate

100.0%

Based on 8 completed trials

Completion Rate

100%(8/8)

Active Trials

3(25%)

Results Posted

50%(4 trials)

Phase Distribution

Ph phase_1

17%

Ph phase_4

Ph not_applicable

58%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution10 total trials

Phase 1Safety & dosage

2(20.0%)

Phase 4Post-market surveillance

1(10.0%)

N/ANon-phased studies

7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(8)

Other(1)

Detailed Status

Completed8

Active, not recruiting2

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (20.0%)

Phase 41 (10.0%)

N/A7 (70.0%)

Trials by Status

completed867%

unknown18%

recruiting18%

active_not_recruiting217%

Recent Activity

3 active trials

Showing 5 of 12

active_not_recruitingnot_applicable

Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes

NCT04754581

active_not_recruitingnot_applicable

Clinical Trials (12)

Showing 12 of 12 trials

NCT04754581Not Applicable

Dynamic in Vivo PET Imaging and ex Vivo Biopsies From Skeletal Muscle and Adipose Tissue to Investigate the Effects of Exercise on Insulin Resistance and Mitochondrial Energetics in Type 2 Diabetes

Active Not Recruiting

NCT02653092Not Applicable

Reprometabolic Syndrome Mediates Subfertility in Obesity

Active Not Recruiting

NCT06739473Phase 4

Total-body Glucose Utilization in Obesity

Recruiting

NCT02517307Not Applicable

Fatty Acid Oxidation Defects and Insulin Sensitivity

Completed

NCT01397279Not Applicable

Assessment of Liver Glucose Metabolism in Diabetic Subjects

Completed

NCT03106688Not Applicable

Neuromolecular Risk Factors for Obesity (PROSPECT)

Unknown

NCT03234751Phase 1

Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

Completed

NCT03003793

Insulin Sensitivity in Patients With Atopic Dermatitis

Completed

NCT03461510Not Applicable

Type 2 Diabetes and the Brain in Adolescents

Completed

NCT02971202Phase 1

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

Completed

NCT02933645Not Applicable

Effects of Intranasal Insulin Administration on Tissue Specific Insulin Sensitivity

Completed

NCT01680133

Regulation of Tissue Lipolysis by Insulin in Type 2 Diabetes

Completed

All 12 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 12